Grand Rapids, MI. – December 1st, 2021 – Genesis Innovation Group’s cultivate(MD) Capital Funds announces that one of their portfolio companies, Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, has raised $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird Capital, with significant […]
HAPPE Spine announces that it has closed on a $3.35 million Series A capital raise.
HAPPE Spine Announces Close Of $3.35 Million Round In Series A Investment Read More »
Company Begins IDE Study, Advancing Goal of Bringing Robotically Assisted Surgery to Any U.S. Hospital or Ambulatory Surgery Center
HOLLAND, Mich., August 9th, 2021—Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, SpinTech, has received FDA 510(k) clearance for their STAGE™ magnetic resonance imaging software. SpinTech is a privately-held medical device company at the frontier
SpinTech Receives FDA 510(K) Clearance for STAGE™ Technology Read More »
HOLLAND, Mich., May 24, 2021 – Genesis Innovation Group\’s cultivate(MD) Seed II Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Wheaton, IL-based Medical Ingenuities, LLC, a medical device company that has developed a novel PH Band™ radial artery occlusion device, has closed its
cultivate(MD) Announces Investment Into Medical Ingenuities Read More »
HOLLAND, Mich., May 10th, 2021 – Shoulder Innovations (SI), an emerging leader in the development of shoulder replacement systems, announced today that it has signed an exclusive license agreement for Genesis Software Innovation‘s “GSI“ PreView Shoulder™ Arthroplasty Planning Software, which recently achieved FDA 510(k) clearance. This clearance is the first musculoskeletal solution under the FDA’s
